Megan currently works as Director, Scientific Affairs and Training Programs at BioCanRx, a federally funded network focused on the development of novel approaches in the treatment of cancer using immunotherapy. Since joining BioCanRx in 2017, she has developed and overseen training initiatives aimed at bridging the gap and growing the talent pool in translational expertise related to cell and virus-based therapeutic development. Prior to joining BioCanRx, Megan was Operations Manager for the Biotherapeutics Manufacturing Centre (BMC) Virus Facility at the Ottawa Hospital Research Institute. In this role, she oversaw the operational activities of the BMC, which specializes in virus and vaccine development and manufacturing services for products destined for pre-clinical and clinical research. Megan is also a program advisor for the Science to Business Network and a program committee member for the Canadian Science Policy Centre. Megan received her PhD in Neuroscience from Queen's University in 2014.